Provepharm Overview


AN INDEPENDENT, INTERNATIONAL SPECIALTY PHARMACEUTICAL COMPANY Pioneering an alternative way of product development: between biotechnology and generics


<p>At&nbsp;Provepharm, we innovate to realize each molecule's full potential, to provide treatments that help improve patients' lives.</p><p><a href="https://online.flippingbook.com/view/792643605/">Discover our new brochure here</a><a href="https://online.flippingbook.com/view/394684859/">.</a></p>

1,8
<p>Million units sold</p>
160 collaborators
<p>(75% in Europe + 25% in the United States)</p>
34 Marketing
<p>Authorizations in 38 countries</p>
10
<p>Patent families</p>

An International Player

Wysiwyg

Headquarters in Marseille, France. 
Operations and direct sales in France, the United States and the United Kingdom. 
20+ distribution partners worlwide.

Our Governance An active Board of Directors

You are about to leave the Provepharm Corporate website. If you continue you will reach the website of our US subsidiary which information is not necessarily applicable to France.

You are about to leave the Provepharm Corporate website. If you continue you will reach the website of our UK subsidiary which information is not necessarily applicable to France.